Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -33.88% is 14% above its 5-year average of -39.34%, around the middle of its 5-year range (-63.01%–-14.22%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.74% below its 12-month average of -30.59%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -33.88%.
RETURN ON INVESTED CAPITAL (ROIC)
-33.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-30.59%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-42.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-39.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-32.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-10.74%
CURRENT VS 3Y AVG
+19.40%
CURRENT VS 5Y AVG
+13.88%
CURRENT VS 10Y AVG
-5.14%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+4.96%
vs the sector median at left
Exagen Inc.
Market Cap
$197.87M
Return on Invested Capital (ROIC)
-33.88%
TTM Avg
-30.59%
3Y Avg
-42.03%
5Y Avg
-39.34%
Market Cap
$198.33M
Return on Invested Capital (ROIC)
-33.10%
TTM Avg
-20.50%
3Y Avg
-16.94%
5Y Avg
-23.40%
Market Cap
$197.18M
Return on Invested Capital (ROIC)
-41.61%
TTM Avg
-54.73%
3Y Avg
-70.67%
5Y Avg
-64.43%
Market Cap
$200.96M
Return on Invested Capital (ROIC)
-71.04%
TTM Avg
-53.65%
3Y Avg
-40.34%
5Y Avg
-35.55%
Market Cap
$192.49M
Return on Invested Capital (ROIC)
-20.24%
TTM Avg
-14.71%
3Y Avg
-27.01%
5Y Avg
-29.46%
Market Cap
$190.07M
Return on Invested Capital (ROIC)
-105.17%
TTM Avg
-54.92%
3Y Avg
-54.02%
5Y Avg
-50.29%
Market Cap
$205.80M
Return on Invested Capital (ROIC)
-47.05%
TTM Avg
-105.31%
3Y Avg
-79.09%
5Y Avg
-78.87%
Market Cap
$189.11M
Return on Invested Capital (ROIC)
-74.02%
TTM Avg
-48.91%
3Y Avg
-62.69%
5Y Avg
-47.07%
Market Cap
$207.27M
Return on Invested Capital (ROIC)
14.99%
TTM Avg
15.04%
3Y Avg
13.17%
5Y Avg
12.12%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Exagen Inc. (XGN) | $197.87M | -33.88% | -30.59% | -42.03% | -39.34% |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $198.33M | -33.10% | -20.50% | -16.94% | -23.40% |
| Surrozen, Inc. (SRZN)vs › | $197.18M | -41.61% | -54.73% | -70.67% | -64.43% |
| Alector, Inc. (ALEC)vs › | $200.96M | -71.04% | -53.65% | -40.34% | -35.55% |
| RxSight, Inc. (RXST)vs › | $192.49M | -20.24% | -14.71% | -27.01% | -29.46% |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $190.07M | -105.17% | -54.92% | -54.02% | -50.29% |
| Whitehawk Therapeutics Inc (WHWK)vs › | $205.80M | -47.05% | -105.31% | -79.09% | -78.87% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | -74.02% | -48.91% | -62.69% | -47.07% |
| Pro-Dex, Inc. (PDEX)vs › | $207.27M | 14.99% | 15.04% | 13.17% | 12.12% |
| Electra Therapeutics Inc. (ETRA)vs › | $208.31M | N/A | N/A | N/A | N/A |
ROIC
-33.9%
ROE
-154.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -33.88% |
| 2026-03-31 | -35.32% |
| 2025-12-31 | -31.61% |
| 2025-09-30 | -23.57% |
| 2025-06-30 | -28.58% |
| 2025-03-31 | -48.55% |
| 2024-12-31 | -43.14% |
| 2024-09-30 | -43.68% |
| 2024-06-30 | -39.24% |
| 2024-03-31 | -42.88% |
| 2023-12-31 | -50.41% |
| 2023-09-30 | -63.01% |
| 2023-06-30 | -62.56% |
| 2023-03-31 | -62.77% |
| 2022-12-31 | -59.97% |
| 2022-09-30 | -41.89% |
| 2022-06-30 | -37.19% |
| 2022-03-31 | -25.58% |
| 2021-12-31 | -20.98% |
| 2021-09-30 | -17.11% |
| 2021-06-30 | -14.22% |
| 2021-03-31 | -11.94% |
| 2020-12-31 | -21.82% |
| 2020-09-30 | -21.31% |
| 2020-06-30 | -18.26% |
| 2020-03-31 | -16.36% |
| 2019-12-31 | -11.28% |
| 2019-09-30 | -7.75% |
| 2019-06-30 | -21.12% |
| 2019-03-31 | -18.43% |
| 2018-12-31 | -24.48% |
| 2015-12-31 | -186.53% |
| 2015-09-30 | -203.74% |
| 2015-06-30 | -182.48% |
| 2015-03-31 | -139.71% |
| 2014-12-31 | -124.50% |
| 2014-09-30 | -98.12% |
| 2014-06-30 | -89.49% |
| 2014-03-31 | -60.21% |
| 2013-12-31 | -58.05% |
